Literature DB >> 17879275

Time trends of physician visits for Crohn's disease and ulcerative colitis in the United States, 1960-2006.

Amnon Sonnenberg1, Joanne Chang.   

Abstract

BACKGROUND: The purpose of this study was to analyze physician visits associated with inflammatory bowel disease in the United States in order to shed light on the underlying disease time trends in the United States.
METHODS: The National Diseases and Therapeutic Index of IMS America from 1960 until 2006 was used as the data source. Survey data had been obtained from a representative sample of U.S. physicians 4 times per year during a 48-hour period and extrapolated to a national level. All physician visits for Crohn's disease and ulcerative colitis were expressed as rates per 100,000 people living in the United States.
RESULTS: Physician visits for Crohn's disease increased almost 5-fold between 1960-1964 and 1990-1994 and have leveled off since then. Except for a slight decrease between 1960-1964 and 1980-1984, physician visits for ulcerative colitis have remained largely unchanged, especially during the most recent 15 years. Similar trends were observed for both men and women.
CONCLUSIONS: U.S. time trends of physician visits are similar to other previously published time trends of inflammatory bowel disease. It appears that the overall incidence of inflammatory bowel disease has remained stable in the past 15 years.

Entities:  

Mesh:

Year:  2008        PMID: 17879275     DOI: 10.1002/ibd.20273

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

1.  Chronic constipation: new diagnostic and treatment approaches.

Authors:  Brian E Lacy; John M Levenick; Michael Crowell
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  Position of the Canadian Association of Gastroenterology on subsequent entry biologics is challenged by biosimilar industry representatives.

Authors:  Miklos Sebeszta; Alex Kudrin
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09

3.  Pros and cons of medical management of ulcerative colitis.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Clin Colon Rectal Surg       Date:  2010-12

4.  Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

Authors:  S Ballou; W Hirsch; P Singh; V Rangan; J Nee; J Iturrino; T Sommers; J Zubiago; N Sengupta; A Bollom; M Jones; A C Moss; S N Flier; A S Cheifetz; A Lembo
Journal:  Aliment Pharmacol Ther       Date:  2018-02-07       Impact factor: 8.171

5.  Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006.

Authors:  Amnon Sonnenberg; Peter A Richardson; Neena S Abraham
Journal:  Dig Dis Sci       Date:  2009-03-04       Impact factor: 3.199

6.  Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease.

Authors:  Marrieth G Rubio; Kofi Amo-Mensah; James M Gray; Vu Q Nguyen; Sam Nakat; Douglas Grider; Kim Love; James H Boone; Dario Sorrentino
Journal:  World J Gastrointest Pathophysiol       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.